A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)

Clinical trial NCT01354990 · COMPLETED

Trial details

NCT number: NCT01354990
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2009-02-01
Primary completion: 2010-05-01
Enrollment: 2974

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.